Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Juan Carlos Del Rio Valencia"'
Autor:
Cristina Lopez Escola, Alvaro Flores, Marta Robles, Harry Donnelly, Darlene Hercules, Kyle Gomez, Juan Roman, Juan Carlos Del Rio Valencia, Mamta Moreno, David Ballesteros
Publikováno v:
Lung Cancer. 178:S46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0e462507c69eb90cfdc58f6c7e5030e
https://doi.org/10.1016/s0169-5002(23)00534-2
https://doi.org/10.1016/s0169-5002(23)00534-2
Publikováno v:
Can J Hosp Pharm
Background: Real-world data are critical to demonstrate the reproducibility of evidence and the external generalizability of randomized clinical trials. Palbociclib is an oral small-molecule inhibitor of cyclin-dependent kinases 4/6 that has been sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94ec21a16ca0c11d1ce68ddf36c1b476
https://www.cjhp-online.ca/index.php/cjhp/article/download/3252/4640
https://www.cjhp-online.ca/index.php/cjhp/article/download/3252/4640
Autor:
Rocio Tamayo-Bermejo, Juan Carlos del Rio-Valencia, Beatriz Mora-Rodriguez, Isabel Muñoz-Castillo
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction Immunotherapy has become a standard treatment for lung cancer; the objective of this study was to evaluate the effectiveness, safety of pembrolizumab monotherapy in patients with advanced or metastatic non-small-cell lung cancer used in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3bfd299f729844aaf49ba7e136ff1d1
https://pubmed.ncbi.nlm.nih.gov/34931913
https://pubmed.ncbi.nlm.nih.gov/34931913
Autor:
Beatriz Mora Rodríguez, Rocio Tamayo-Bermejo, Juan Carlos Del Rio-Valencia, Casillo-Muñoz Isabel
Introduction: Immunotherapy has become a standard treatment for lung cancer; the objective of this study was to evaluate the effectiveness, safety of pembrolizumab monotherapy in patients with advanced or metastatic Non-Small Cell Lung Cancer (NSCLC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9b9c2654de2523bc5c80ac72fdcc6dd
https://doi.org/10.22541/au.159957150.04571440
https://doi.org/10.22541/au.159957150.04571440
Autor:
Aranzazu Linares-Alarcón, Manuel Ángel Castaño-Carracedo, L Yunquera-Romero, R Asensi-Diez, Juan Carlos del Rio-Valencia, I Muñoz-Castillo
Publikováno v:
Journal of AIDS & Clinical Research.
Introduction: Boosted protease inhibitor monotherapy (PI/r ) : Darunavir/ritonavir (DRV/r) or Lopinavir/ritonavir (LPV/r) monotherapy is only provided in the major treatment guidelines in pre-treated HIV patients to prevent toxicity associated with n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::daec59c701228e9396e49f60017ed517
https://doi.org/10.4172/2155-6113.1000666
https://doi.org/10.4172/2155-6113.1000666
Autor:
Del Rio-Valencia JC; Juan Carlos del Rio-Valencia. Hospital Regional Universitario de Málaga. Avenida de Carlos Haya s/n. CP.29010. Málaga. Spain. juancardelrio@telefonica.net., Asensi-Diez R, Tamayo-Bermejo R, Muñoz-Castillo I
Publikováno v:
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2019 Aug; Vol. 32 (4), pp. 296-302. Date of Electronic Publication: 2019 Jun 21.
Autor:
Del Rio-Valencia JC; Juan Carlos del Rio-Valencia, Hospital Regional Universitario de Málaga. Avenida de Carlos Haya s/n. CP.29010. Málaga. Spain. juancardelrio@telefonica.net., Asensi-Diez R, Villalobos-Torres L, Muñoz Castillo I
Publikováno v:
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia [Rev Esp Quimioter] 2018 Jun; Vol. 31 (3), pp. 226-236. Date of Electronic Publication: 2018 May 16.